Posts Tagged ‘jobs in science’

CK Science Salary Survey 2013

Friday, February 15th, 2013

Your chance to complete the 2013 CK Science Salary Survey is almost over.

Science jobsThe science salary survey will be closing at the end of February so this is the last chance you will have to  take part. It takes only 5 minutes to complete, and your participation will help us understand what the 2012 science salary brackets were. The results of this survey will be published and will help you with your job and salary expectations for 2013.

Click on the link below to complete the CK Science Salary Survey

https://www.surveymonkey.com/s/cksciencesalarysurvey

 Are you are currently looking for a job within the Science industry?

Click here to view all our science jobs

Science jobs uk   Science jobs UK

 

£90m lab opens in Glasgow

Wednesday, November 14th, 2012

As reported on The Journal, A £90m laboratory facility has been opened on the site of the Southern General Hospital based in Glasgow. Work at the lab will focus on developing lifesaving genetic treatments.

Over 700 staff are employed at the new laboratory facilities including medical personnel, clinical scientists, biomedical scientists, technical assistants, administrative and clerical staff.

The state of the art laboratories will enable ground-breaking services for biochemistry, haematology, microbiology, genetics and pathology. It is hoped that analytical tests will be performed faster and new tests will be developed to aid the diagnosis of medical conditions and to develop genetic treatments.

 

Are you looking for a new job in science? Click here to search our science jobs now >

 

£90m lab opens in Glasgow   £90m lab opens in Glasgow   £90m lab opens in Glasgow   £90m lab opens in Glasgow

A new-state-of-the-art Science park will bring 2,000 jobs to Wiltshire

Thursday, October 25th, 2012

ThA new-state-of-the-art Science park will bring 2,000 jobs to Wiltshiree Swindon Advertiser has reported that a new state-of-the-art science park will be developed at Porton in Wiltshire creating more than 2,000 jobs over a 10-year-period and bringing national and international investment into the area.

Wiltshire Council and a joint development company, comprising Trebor Developments LLP and Wrenbridge Land Limited, will develop the science park. The successfully bided  for £10m funding from the Department of Business, Innovation and Skills (BIS). This will help kick-start the first phase of the science park project, creating the infrastructure for the planned 355,000 sq ft science park and a new 23,000 sq ft innovation centre

This new science park will  provide facilities for science- and research-based industries and could attract £70m of private sector investment over the next 10 years.

 

Are you looking for a new science based role?

Click here to see our latest science jobs

GSK invest 10 million euros at their facility in Sligo, Ireland

Thursday, October 18th, 2012

Pharmatimes have reported that GlaxoSmithKline has decided to keep open its facility in Sligo Ireland and will instead invest 10 million euros into the plant.

GSK acquired the facility in Sligo when GSK bought the dermatology specialist Stiefel Laboratories for up to $3.6 billion in 2009.

There will be some jobs cuts at the plant over the next two years, which currently employs 180 people, with a “gradual” reduction to 120. However, GlaxoSmthKline estimated there would be an additional 50 jobs added in 2014 as the plant improved skills and capacity.

 

If you are looking for a new job in science why not look at our current science based vacancies?

Click here to see our latest jobs in the science industry

Allergans Botox receives UK approval for treatment of MS/spinal injury

Tuesday, October 2nd, 2012

CK Science - Scientific Recruitment AgencyPharmaTimes have reported that Allergan’s Botox is now licensed in the UK for patients who have continence issues because of multiple sclerosis or a spinal injury.

The Medicines and Healthcare products Regulatory Agency has give Allergan permission to use Botox (botulinum toxin type A) for managing urinary incontinence caused by neurogenic detrusor overactivity due to subcervical spinal cord injury or multiple sclerosis (MS),

Professor Christopher Chapple, Urology Department, Royal Hallamshire Hospital, Sheffield NHS Trust and a key investigator in the neurogenic detrusor overactivity registration trials, has welcomed the new license, noting that “being able to better control and manage bladder function can be life-changing for patients”.

 

If you are looking for a new job in science why not look at our current science based vacancies?

Click here to see our latest jobs in the science industry

UCB launches its new biotechnology facility in Belgium

Tuesday, September 18th, 2012

PharmaTimes has reported that UCB has launched its 65 million euro pilot biotechnology plant in Belgium.

The new facility is located at its Braine-l’Alleud site and will employ 100 employees. This new facility will produce cell culture-based therapeutic proteins that are dedicated to accelerating the availability of new drugs for severe diseases with a focus on the research and clinical trial phases

This new facility is designed enable UCB to improve its biological medicines.

Chief executive Roch Doliveux said that “today, 33% of drugs for human use worldwide are of biotechnological origin and represent more than half of UCB’s current R&D pipeline”. He added that “with this bio pilot plant, we will more rapidly initiate clinical studies of new antibody-based therapeutics”.

 

Are you looking for a new science based role?

Click here to see our latest science jobs

Novartis’s rare cancer drug is launched in the UK

Tuesday, September 11th, 2012

Pharmatimes have reported that Novartis have launched their new drug Jakavi which means for the first time patients in the UK with a rare form of blood cancer will now have access to this targeted therapy

Jakavi (ruxolitinib) is a first-in-class JAK 1 and JAK 2 inhibitor, and is now available to treat patients in the UK with disease-related enlarged spleen or various forms of myelofibrosis, which affects around 0.34-0.76 people in every 100,000.

Myelofibrosis is a rare, potentially life-threatening blood cancer characterised by bone marrow failure, enlarged spleen and debilitating symptoms including extreme fatigue, poor quality of life and weight loss, and shortened survival.

Jakavi received EU approval at the end of August 2012

 

Are you looking for a new job in the pharmaceutical  industry?

Click here to see our latest pharmaceutical jobs?

£2.8 billion renewable energy investment in Scotland

Thursday, August 16th, 2012

Scottish Development International has reported that Scotland’s renewable energy industry has attracted £2.8 billion capital investment since 2009.

Onshore wind accounts for 57 percent of total investment with 21 percent going to offshore wind. The rest of the investment has been deivded between wave and tidal energy, solar photovoltaic, hydro energy, landfill gas and biofuels.

Niall Stuart, chief executive of Scottish Renewables said “These figures show Scotland’s renewables industry is very much bucking the economic trend.  During the downturn our industry has delivered some £2.8bn of much needed capital investment in our economy.  This has helped to grow the supply chain, secure the future of many companies and support more than 11,000 jobs”

 

Are you looking for a new science based role?

Click here to see our latest science jobs

Grapefruit juice can help lower the dosage of cancer drugs needed

Thursday, August 9th, 2012

As reported by WorldPharmaNews, results of a clinical trial have showed that a glass a day of grapefruit juice lets patients derive the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself.

Researchers at the University of Chicago Medicine study the effects that foods can have on the uptake and elimination of drugs used for cancer treatment. 

In the study, they found that eight ounces a day of grapefruit juice can slow the body’s metabolism of a drug called sirolimus, which has been approved for transplant patients but may also help many people with cancer.

Patients who drank eight ounces a day of grapefruit juice increased their sirolimus levels by 350 percent. A drug called ketoconazole that also slows drug metabolism increased sirolimus levels by 500 percent.

The hope is that this combination could help patients avoid side effects associated with high doses of the drug and reduce the cost of the medication.

 

Click here to see our latest pharmaceutical jobs

      

Science Jobs in Ireland

Monday, August 6th, 2012

Hannah Milward and Naynesh Mistry at CK Science currently have quite a few exciting vacancies in Ireland.

Hannah and Naynesh have made a short video featured below to give us more information about these jobs:

 

YouTube Preview Image.

 

 

Here are is a bit more information for  the jobs mentioned in the video, please click on the links:

Materials Development Engineer – Ireland

Materials Engineer (Polymer Chemist)

Metrology Engineer – Ireland

Validation Engineer, Medical Devices

 

How to apply:

If you would like more information or to apply for one of these jobs please contact Hannah or Naynesh on 0114 283 9956 or email hmilward@ckscience.co.uk / nmistry@ckscience.co.uk

                 

 

 

 

Search for a job

Advanced search

20 years Download the CK Science iPhone App

Subscribe to our newsletter

Preview
Powered by FeedBlitz


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close